Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Results of operations
  2. 10-Q Report Quarterly Report
  3. 8-K/A Event Executive or director change
  4. 8-K Event Shareholder vote results
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award General Counsel acquired 1,812 shares (grant or award)
  12. 4 Grant or award Principal Accounting Officer acquired 1,812 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 695 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Executive or director change
  16. 4/A Gift Director gave 3,900 shares (gift)
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 23 of 41 · 801 filings